The Global Neurovascular Devices Market size is expected to reach $4.2 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.
Neurovascular devices are used to treat neurovascular conditions. Stents, coils, and clips are examples of neurovascular devices used to treat conditions like brain aneurysms. Similar devices are used to remove blood clots from the brain's arteries and veins, which can result in life-threatening disorders like stroke. This equipment includes suction and aspiration devices. Furthermore, ischemic stroke, stenosis, aneurysm, arteriovenous malformation, and fistulas are a few other neurovascular disorders that can be treated with the help of neurovascular devices.
Central nervous system or brain vascular disorders are diagnosed and treated with interventional neurology technologies. Interventional neurology includes angiography, endovascular operations, fluoroscopy, and catheter-based procedures. For example, several neurological illnesses, such as arteriovenous malformations, cerebral aneurysm, arteriovenous fistula, intracranial stenosis, and vasculitis, can be diagnosed with catheter angiography, one of the earliest in-vivo brain vascular imaging procedures.
Due to the decreased danger and trauma involved with these treatments, minimally invasive procedures are becoming increasingly common. In addition, smaller incisions reduce postoperative pain and speed up healing, resulting in high adoption of these operations and increasing R&D in this area. To bring cutting-edge minimally invasive surgical equipment to market, several important firms are investing in R&D. One of the minimally invasive procedures that doctors highly suggest is the endovascular coiling used to treat cerebral aneurysms.
During this surgery, a microcatheter is placed via the aneurysm-containing artery in the groin area. Platinum coils are released to encourage aneurysm coagulation and stop blood from entering other parts of the brain. The considerable volume of neurovascular devices consumed, which has contributed to the market expansion, is primarily due to the fast-expanding patient population for the target disorders across the key markets.
The neurovascular market has suffered due to the limited accessibility of medical care for disorders other than COVID-19 globally. Another element that has a detrimental impact on the market for neurovascular devices is the scarce availability of medical personnel globally. The market has also been negatively influenced by surgeries that aren't essential and can be delayed, such as those for brain aneurysms. On the other hand, the ischemic stroke section is less affected since people who have an ischemic stroke need immediate medical intervention.
Minimally invasive medical techniques offer more therapeutic benefits than traditional surgical procedures, including a shorter hospital stay, quicker patient recovery, increased procedure effectiveness and safety, and lower costs. Hence, market acceptability and demand for minimally invasive surgical treatments are increasing among medical professionals globally. Elderly patients are more prone to neurological and neurovascular disorders. They choose treatment methods that offer simple diagnosis, straightforward treatments, increased safety, the shortest hospital stay feasible, superior efficacy, and affordable costs. These factors are estimated to support the expansion of the neurovascular devices market in the near future.
Strokes are among the leading cause of mortality worldwide, and the prevalence is very high in the United States. Globally, there are more strokes than ever before because of an array of reasons, including growing urbanization, a sedentary lifestyle, and stress. Also, the condition significantly contributes to the annual mortality toll globally. These trends are creating a sizable patient base that has to be treated. Throughout the forecast period, it is predicted that this, along with rising patient awareness regarding the availability of treatment and reimbursement for neurovascular disorders, particularly in emerging nations, will further accelerate the expansion of the neurovascular devices market.
The high price of neurovascular procedures and equipment is a major issue that is constraining the market for neurovascular devices, particularly in emerging nations having poor reimbursement policies. In addition, the cost of maintenance and any other associated indirect charges contribute to an increase in the overall price of these devices, which in turn limits the adoption of these technologies. Due to financial constraints, freestanding ambulatory surgery centers and small hospitals are less likely to invest in costly and advanced technologies. Thus, the high cost of neurovascular procedures may decline the growth of the neurovascular devices market in the upcoming years.
Based on technology, the neurovascular devices market is segmented into embolization & coiling, cerebral balloon angioplasty & stenting systems, support devices, and neuro-thrombectomy devices. In 2021, the embolization & coiling devices segment held the highest revenue share in the neurovascular devices market. Neurovascular conditions such as carotid artery diseases, arteriovenous malformations (AVMs), and intracranial atherosclerotic diseases frequently necessitate embolization devices. In addition, other factors, including the rapid introduction of new and innovative neurovascular devices, contribute to the market's expansion.
On the basis of disease pathology, the neurovascular devices market is classified into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations & fistulas and other diseases. The ischemic stroke segment acquired a substantial revenue share in the neurovascular devices market in 2021. Globally, ischemic stroke is becoming more common. To avoid ischemic stroke in patients, the American Heart Association advises using stent retrieval devices to remove blood clots. The need for neurovascular devices is expected to rise in the coming years due to the rising number of cases of ischemia.
By end user, the neurovascular devices market is bifurcated into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The ambulatory care centers segment recorded a remarkable revenue share in the neurovascular devices market in 2021. Patients' decreased wait times at ASCs are anticipated to drive the segment's significant growth during the projected period. In addition, the segment's growth is propelling due to the presence of skilled professionals in such healthcare facilities.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 2.4 Billion |
| Market size forecast in 2028 | USD 4.2 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 8.8% from 2022 to 2028 |
| Number of Pages | 408 |
| Number of Table | 719 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Technology, Disease Pathology, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the neurovascular devices market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region dominated the neurovascular devices market with the largest revenue share. The neurovascular devices market in North America is mainly fueled by variables such as the substantial disease burden, the increase in minimally invasive neurology treatments, and the establishment of trauma/emergency care facilities in the United States. In addition, technological advances and increased research and development activities resulting in product releases are driving regional market expansion.
Free Valuable Insights: Global Neurovascular Devices Market size to reach USD 4.2 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
By End User
By Technology
By Disease Pathology
By Geography
The global Neurovascular Devices Market size is expected to reach $4.2 billion by 2028.
Growing demand for minimally invasive procedures are driving the market in coming years, however, High cost to be spent on neurovascular surgeries & relative products restraints the growth of the market.
Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
The expected CAGR of the Neurovascular Devices Market is 8.8% from 2022 to 2028.
The Hospital & Surgery Centers segment acquired maximum revenue share in the Global Neurovascular Devices Market by End User in 2021 thereby, achieving a market value of $2.8 billion by 2028.
The North America market dominated the Global Neurovascular Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.6 billion by 2028.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
